| A patent internal mammary artery graft decreases the risk of reoperative coronary artery bypass surgery. | |
| | |
MedLine Citation:
|
PMID: 7914765 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
In order to evaluate the potential risks of a patent internal mammary artery bypass at reoperative coronary artery bypass grafting, we have reviewed the records of 233 consecutive patients undergoing reoperative coronary artery bypass grafting between 1 January 1991 and 31 December 1993, including 209 patients having an occluded mammary graft or no mammary graft (Group I) and 24 patients having a patent mammary graft (Group II). With regard to preoperative patient characteristics, the only significant differences between the groups were: Group II patients had a higher preoperative left ventricular ejection fraction than did Group I patients (63.7% +/- 8.9% vs. 52.1% +/- 10.1%, p < 0.001); and Group II patients had received fewer grafts per patient than had patients in Group I (2.2 +/- 1.1 vs 3.6 +/- 1.4 grafts per patient, p < 0.001). There were no entry injuries to the grafts or to the heart in either of the groups. No perioperative mortality was encountered in Group II, while 11 patients died in Group I (p < 0.05). Group II had a significantly higher incidence of reexploration for post-operative bleeding, whereas Group I had a significantly higher incidence of low postoperative cardiac output. The incidence of all other perioperative complications did not differ between the groups. The results of this study support the use of mammary grafts even in patients who are likely to need repeat coronary artery bypass grafting and certainly does not disqualify such patients from a 2nd operation. |
| | |
Authors:
|
V Velebit; J T Christenson; J Maurice; F Simonet; M Schmuziger |
Related Documents
:
|
2939265 - Axillofemoral bypass: a tool with a limited role. 17593095 - Dissociation of sexual function and sexual bother following autologous sural nerve graf... 23383185 - Long-term efficacy of first line antiretroviral therapy in indian hiv-1 infected patien... 23100925 - Cefepime versus ceftazidime as empirical therapy for fever in neutropenic patients with... 22806485 - Evaluation of a therapeutic vaccine for the prevention of recurrent urinary tract infec... 22191465 - Operational cures after interferon-alpha in patients with chronic myeloid leukemia in c... |
Publication Detail:
|
Type: Comparative Study; Journal Article |
Journal Detail:
|
Title: Texas Heart Institute journal / from the Texas Heart Institute of St. Luke's Episcopal Hospital, Texas Children's Hospital Volume: 21 ISSN: 0730-2347 ISO Abbreviation: Tex Heart Inst J Publication Date: 1994 |
Date Detail:
|
Created Date: 1994-09-22 Completed Date: 1994-09-22 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 8214622 Medline TA: Tex Heart Inst J Country: UNITED STATES |
Other Details:
|
Languages: eng Pagination: 125-9 Citation Subset: IM |
Affiliation:
|
Cardiovascular Surgery Unit, Hôpital de la Tour, Meyrin-Geneva, Switzerland. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Coronary Artery Bypass*
/
mortality Coronary Disease / epidemiology, surgery* Female Graft Occlusion, Vascular / epidemiology* Humans Incidence Male Middle Aged Myocardial Revascularization* Postoperative Complications / epidemiology Reoperation Risk Factors Saphenous Vein / transplantation Vascular Patency / physiology |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Placental infections with Plasmodium in an endemic zone. Risk factors
Next Document: New surgical technique for harvesting the internal mammary artery.